REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Solid Synthetic Organic Polymer As Designated Organic Active Ingredient (doai) > Monomer Contains Oxygen > Oxygen Heterocycle Oxygen HeterocycleOxygen Heterocycle patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.05/24/07 - 20070116667 - Colon cleansing compositions and methods A composition comprising, per litre of aqueous solution, from 30 to 350 g polyethylene glycol, from 3 to 20 g of an ascorbic acid component selected form the group consisting of ascorbic acid, a salt of ascorbic acid, or a mixture thereof, an alkali metal or alkaline earth metal sulphate, ... 04/19/07 - 20070086978 - Colon cleansing compositions and methods A composition comprising, per litre of aqueous solution, from 30 to 350 g polyethylene glycol, from 3 to 20 g of an ascorbic acid component selected form the group consisting of ascorbic acid, a salt of ascorbic acid, or a mixture thereof, an alkali metal or alkaline earth metal sulphate, ... 03/08/07 - 20070053869 - Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents The present invention relates to a method of enhancing absorption of a pharmaceutical agent by administering the agent in combination with an inhibitor of BCRP/ABCG2 wherein the amount of the inhibitor is about the critical micelle concentration of the inhibitor or less than the critical micelle concentration. The invention also ... 03/08/07 - 20070053868 - Solvent system for enhancing the solubility of pharmaceutical agents Liquid and semi-solid pharmaceutical compositions, which can be administered in liquid form or can be used for preparing capsules, are described herein. The composition comprises the salt of one ore more active agents, polyethylene glycol, 0.2-1.0 mole equivalents of a de-ionizing agent per mole of active agent, and water. The ... 03/01/07 - 20070048252 - Conjugates of the hydrophilic polymer and the molecules from boxwood extraction, and pharmaceutical compositions of the conjugates The present invention relates to a group of conjugates of the hydrophilic polymers and the molecules from boxwood extraction. PEGylation process or the process alike was used to generate the conjugates, which have increased water solubility and prolonged the circulation half-life in the body. ... 01/25/07 - 20070020228 - Method of using a biosealant device Currently used techniques for sealing impaired tissue following medical procedures are not optimal. Manual compression, though effective, is time consuming and current sealing products use animal proteins, which can cause immunological reactions and disease. Therefore, a desirable product is one that easily and effectively seals a wound in tissue without ... 11/30/06 - 20060269512 - Non-lithotripsic kidney-stone therapy One aspect of the present invention relates to a method of using peristalsis to force a polymer plug through a mammalian lumen, thereby removing any calculi and/or calculi fragments present in the lumen. In one embodiment, the method is used as an alternative to conventional lithotripsy. In another embodiment, the ... 10/05/06 - 20060222623 - Composition for treating dry eye and related methods of manufacture and methods of use The present invention is directed to a composition for treating dry eye comprising, in one embodiment, carboxymethylcellulose and a polyol. Such compositions have been found to alleviate the symptoms of dry eye and remain in the eye for a long period of time. ... 09/07/06 - 20060198818 - Method for analyzing activated polyethylene glycol compounds A chemical analysis method for the determination of RO(CH2CH2O)nH, RO(C2H4O)nA, and AO(C2H4O)nA in a mixture thereof, wherein R is an alkyl group, A is a functional group for coupling with a surface or a biologically active material or another thing of use and n is an interger greater than 10. ... 09/07/06 - 20060198817 - Materials and methods for preventing and treating microbe-mediated epithelial disorders The present invention provides pharmaceutical compositions in the form of relatively high molecular weight biocompatible polymers such as polyethylene glycol, optionally supplemented with a protective polymer such ad dextran and/or essential pathogen nutrients such as L-glutantine. Also provided are methods for preventing or treating gut-derived sepsis attributable to intestinal pathogens ... 08/31/06 - 20060193823 - Hydrolytically degradable carbamate derivatives of poly (ethylene glycol) Poly(ethylene glycol) carbamate derivatives useful as water-soluble pro-drugs are disclosed. These degradable poly(ethylene glycol) carbamate derivatives also have potential applications in controlled hydrolytic degradation of hydrogels. In such degradable hydrogels, drugs may be either trapped in the gel and released by diffusion as the gel degrades, or they may be ... 08/24/06 - 20060188470 - Pes 2000 plus folic acid 1. A therapeutic dose of PES 2000 when taken orally by animals or humans helps to control and prevent epilepsy. ... 08/17/06 - 20060182711 - Conjugates of an epo moiety and a polymer Conjugates of an EPO moiety and one or more non-peptidic water-soluble polymers are provided. Typically, the non-peptidic water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided are compositions comprising such conjugates, methods of making conjugates, and methods of administering compositions comprising such conjugates to a patient. ... 06/29/06 - 20060140904 - Random alkylene oxide copolymers for medical and surgical utilities Medical and surgical uses for random alkylene oxide copolymers have been discovered. Preferably, this is a biocompatible, non-metabolizable, non-toxic, and/or readily eliminated compound that has a viscosity which is adjustable for different utilities (e.g., from runny oil to thick grease). It is also preferable to formulate the compound as an ... 06/01/06 - 20060115450 - Polyalkylene glycol derivative and modified bio-related substance wherein Mw represents a weight average molecular weight and Mn represents a number average molecular weight. ... 05/25/06 - 20060110357 - Bone putty composition that maintains granule suspension at reduced temperatures The invention is directed to a bone putty composition comprising a carrier formulation comprising water and a carrier substance, and granules wherein said bone putty composition exhibits gel-like Theological properties throughout the temperature range between about body temperature and temperatures approaching about 0° C. The bone putty composition further exhibits ... 04/06/06 - 20060073113 - Polyalkylene glycol derivative and modified bio-related substance wherein Mw represents a weight average molecular weight and Mn represents a number average molecular weight. ... 03/02/06 - 20060045866 - Novel high purity and high molecular weight mpeg alcohol compositions The invention is directed toward novel high molecular weight and high purity mPEG alcohol compositions as well as a process for obtaining said compositions by removing PEG diols from the mPEG alcohol after polymerization is complete. ... 02/16/06 - 20060034798 - Water-in-oil emulsions with ethylene oxide groups, compositions, and methods Water-in-oil emulsions, compositions, and methods that include a vinyl polymer that includes ethylene oxide-containing side chains and alkyl-Y-containing side chains, wherein Y is O or NR, wherein R is H or CH3, and wherein the alkyl group of the alkyl-Y-containing side chain has at least 4 carbon atoms on average ... 02/09/06 - 20060029571 - Stabilized hyaluronan preparations and related methods Stabilized hyaluronan preparations wherein hyaluronan is combined with a polyglycol, such as polyethylene glycol. Stabilized hyaluronan preparations of this invention may maintain their viscosity and lubricity for extended time periods (e.g., 2 years) without requiring refrigeration or special storage conditions. ... 02/09/06 - 20060029570 - Therapeutic peg solution concentrate The present invention provides a polyethylene glycol liquid concentrate for treatment of constipation or for gastrointestinal lavage that is chemically stable and resistant to microbial contamination. ... 11/03/05 - 20050244368 - Pre-endoscopic use of polyethylene glycol compositions A method to induce bowel cleansing which employs electrolyte-free polyethylene glycol containing compositions is provided. ... 09/29/05 - 20050214250 - Method of preparing carboxylic acid functionalized polymers Methods for preparing water soluble, non-peptidic polymers carrying carboxyl functional groups, particularly carboxylic acid functionalized poly(ethylene glycol) (PEG) polymers, are disclosed, as are the products of these methods. In general, an ester reagent R(C═O)OR′, where R′ is a tertiary group and R comprises a functional group X, is reacted with ... 08/18/05 - 20050180946 - Hydrophilic polymer derivative with y type branch and preparation method of it medical cpmposite comprising above compund The present invention relates to Y-shape branched PEG derivatives of formulae (I) to (IV). The present invention also relates to conjugates of these Y-shape derivatives and drug molecules, pharmaceutical compositions comprising those conjugates. ... 07/21/05 - 20050158274 - Medical implants and fibrosis-inducing agents Implants are used in combination with a fibrosis-inducing agent in order to induce fibrosis that may otherwise not occur when the implant is placed within an animal or increase fibrosis between the implant and the host tissue. ... 07/07/05 - 20050147585 - Internal clamp for surgical procedures One aspect of the present invention relates to a method of occluding a vascular site in a mammal, comprising the step of introducing into the vasculature of a mammal at or proximal to a surgical site, a composition comprising at least one optionally purified inverse thermosensitive polymer, wherein said inverse ... 06/30/05 - 20050142099 - Composition and method for treatment of hepatic encephalopathy The inventions provide an improved treatment for hepatic encephalopathy characterized by hyperammonemia and/or constipation, comprising the oral administration of polyethylene glycol (PEG) in amounts sufficient to reduce plasma levels of ammonia and/or to alleviate constipation. Preferably, the PEG is administered in combination with lactulose, which provides a palatable composition for ... ### FreshPatents.com Support |